Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Glucotrack, Inc.GCTK · Entity 8422 | Director | August 24, 2021 | March 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Glucotrack, Inc.
Report date August 24, 2021 · Filed March 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 2,045 |
Ending reported balance
After 2025-03-26 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-08-24 · Grant · Acquired 318 · Balance 318 Row 2 · 2024-04-08 · Grant · Acquired 229 · Balance 547 Row 3 · 2025-03-26 · Grant · Acquired 1,498 · Balance 2,045 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2025 Filed Mar 29, 2025 00:53 UTC | Glucotrack, Inc. GCTK · Entity 8422 | GrantCommon Stock, par value $0.001 per share | 1,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000066 · primary_doc.xml · nonDerivative · entry 3 Fischell Robert · CIK 0001557104 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,045 Read SEC document |
| April 08, 2024 Filed Mar 29, 2025 00:53 UTC | Glucotrack, Inc. GCTK · Entity 8422 | GrantCommon Stock, par value $0.001 per share | 229 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000066 · primary_doc.xml · nonDerivative · entry 2 Fischell Robert · CIK 0001557104 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 547 Read SEC document |
| August 24, 2021 Filed Mar 29, 2025 00:53 UTC | Glucotrack, Inc. GCTK · Entity 8422 | GrantCommon Stock, par value $0.001 per share | 318 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000066 · primary_doc.xml · nonDerivative · entry 1 Fischell Robert · CIK 0001557104 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318 Read SEC document |
| June 01, 2017 Filed Jun 7, 2017 21:30 UTC | Glucotrack, Inc. IGAP · Entity 8422 | GrantRestricted Stock Units · Derivative | 22,727 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001178913-17-001757 · zk1720103.xml · derivative · entry 2 Fischell Robert · CIK 0001557104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock, par value $0.001 per share · 22,727 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date. F3 · derivative.expiration_date: The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer. Read SEC document |
| June 01, 2017 Filed Jun 7, 2017 21:30 UTC | Glucotrack, Inc. IGAP · Entity 8422 | GrantOption (Right to buy) · Derivative | 14,894 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001178913-17-001757 · zk1720103.xml · derivative · entry 1 Fischell Robert · CIK 0001557104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,894 Underlying: Common Stock, par value $0.001 per share · 14,894 shares Expires 2027-06-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over a one year period commencing on June 1, 2017. Read SEC document |
| June 01, 2017 Filed Jun 9, 2017 20:13 UTC Amendment | Glucotrack, Inc. IGAP · Entity 8422 | GrantRestricted Stock Units · Derivative | 22,727 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001178913-17-001788 · zk1720121.xml · derivative · entry 1 Fischell Robert · CIK 0001557104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock, par value $0.001 per share · 22,727 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98. F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date. F3 · derivative.expiration_date: After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.